Virtual Screening as a Technique for PPAR Modulator Discovery
Virtual screening (VS) is a discovery technique to identify novel compounds with therapeutic and preventive efficacy against disease. Our current focus is on the in silico screening and discovery of novel peroxisome proliferator-activated receptor-gamma (PPARγ) agonists. It is well recognized that P...
Saved in:
Main Authors: | Stephanie N. Lewis, Josep Bassaganya-Riera, David R. Bevan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2010/861238 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening for PPAR Responsive Regulatory Modules in Cancer
by: Merja Heinäniemi, et al.
Published: (2008-01-01) -
Safety, Tolerability, and Pharmacokinetics of NIM‐1324 an Oral LANCL2 Agonist in a Randomized, Double‐Blind, Placebo‐Controlled Phase I Clinical Trial
by: Andrew Leber, et al.
Published: (2025-01-01) -
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01) -
Discovery of Anti-inflammatory Peptides from Channa argus Using Virtual Screening, Molecular Docking, and Cell Model
by: XIANG Huan, LU Meiming, CHEN Shengjun, HUANG Hui, HU Xiao, ZHAO Yongqiang, WEI Ya
Published: (2024-12-01) -
Discovery of novel PRMT1 inhibitors: a combined approach using AI classification model and traditional virtual screening
by: Jungan Zhang, et al.
Published: (2025-01-01)